Table 1.

Summary of baseline and follow-up assessments for the Pilot Atrial Fibrillation health Literacy Information Technology Trial (Pilot AF-LITT).

Demographics	Age, sex, race
Habits	Smoking (never/former, current); alcohol use
Anthropometry	Body mass index; SBP, DBP
Social, economic factors	Marital status; income, assets, insurance, education
AF assessments, treatment	Date of diagnosis, history of cardioversion/pulmonary vein isolation; anticoagulation history
Prevalent Conditions (definitions)	CHD (prior MI, catheterization, positive stress test)
	History of stroke or transient ischemic attack
	CHF (LVEF<40% or ≥ NYHA II)
	DM (HgbA1c ≥ 7%, medications, history)
	HTN (SBP ≥ 140 mm Hg, DBP ≥ 90 mm Hg, medications)
Medications	Antiarrhythmics, beta and calcium channel blockers, digoxin, anticoagulants (VKA, NOAC, aspirin)
Health-related Quality of Life*	Atrial Fibrillation Effect on QualiTy of life (AFEQT)[19]
Adherence*	Morisky Medication Adherence Scale, 8 items (MMAS-8)[20]
Patient Activation*	Patient Activation Measure[26]
Hospitalization events, Vital status†	Electronic health record, telephone contact

SBP indicates systolic blood pressure; DBP, diastolic blood pressure; CHD, coronary disease; MI, myocardial infarction; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association class; DM, diabetes; HTN, hypertension; VKA, Vitamin K antagonist; NOAC, novel oral anti-coagulant.

^*Indicates assessed at baseline and 30-day follow-up.

^†Indicates assessed at 90 days.